ARISTOTLE CAPITAL BOSTON, LLC – Supernus Pharmaceuticals, Inc. Transaction History
ARISTOTLE CAPITAL BOSTON, LLC portfolio value:
$39.18M
portfolio value
ARISTOTLE CAPITAL BOSTON, LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.69% | -110.18K shares | 2.52M | $33.85 | 1.15M |
| Q2 2022 | share | Increase | +0.77% | 9.67K shares | -3.99M | $28.92 | 1.26M |
| Q1 2022 | share | Decrease | -2.16% | -27.80K shares | 3.16M | $32.32 | 1.25M |
| Q4 2021 | share | Decrease | -2.45% | -32.23K shares | 2.34M | $30.03 | 1.28M |
| Q3 2021 | share | Increase | +24.16% | 256.45K shares | 2.46M | $26.67 | 1.31M |
| Q2 2021 | share | Increase | +9.08% | 88.36K shares | 7.20M | $30.79 | 1.06M |
| Q1 2021 | share | Decrease | -4.73% | -48.33K shares | -223K | $26.18 | 973.29K |
| Q4 2020 | share | Decrease | -4.74% | -50.82K shares | 3.35M | $25.16 | 1.02M |
| Q3 2020 | share | Increase | +4.34% | 44.61K shares | -2.06M | $20.84 | 1.07M |
| Q2 2020 | share | Increase | +38.78% | 287.19K shares | 11.08M | $23.75 | 1.02M |
| Q1 2020 | share | Decrease | -2.23% | -16.86K shares | -4.64M | $17.99 | 740.63K |
| Q4 2019 | share | Increase | +1.82% | 13.51K shares | -2.47M | $23.72 | 757.50K |
| Q3 2019 | share | Increase | +615.16% | 639.96K shares | 17.00M | $27.48 | 743.99K |
| Q2 2019 | share | Increase | 0.00% | 104.03K shares | 3.44M | $33.09 | 104.03K |